Concepedia

NICE's end of life decision making scheme: impact on population health

Marissa Collins, Nicholas Latimer

BMJ · 2013 · 88 citations · 5 references

DOI

Concepts

Abstract

<b>Marissa Collins</b> and <b>Nicholas Latimer</b> quantify the impact of raising the cost effectiveness threshold for end of life drugs and find that the effect on other NHS services could be substantial

References

5

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

Karl Claxton, Steve Martin, Marta Soares et al. · Health Technology Assessment · 2015 · 832 citations · Full text

SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE‐BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS‐SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN

Warren G. Linley, Dyfrig Hughes · Health Economics · 2012 · 196 citations

Valuing health at the end of life: A stated preference discrete choice experiment

Koonal Shah, Aki Tsuchiya, Allan Wailoo · Social Science & Medicine · 2014 · 98 citations · Full text

, , +23

NICE and the challenge of cancer drugs

James Raftery · BMJ · 2009 · 71 citations

Cost of US health reforms is estimated at $1.6 trillion for first 10 years

B. Roehr · BMJ · 2009 · 10 citations

, , +16